Cibc World Market Inc. Sells 51,127 Shares of CVS Health Corporation $CVS

Cibc World Market Inc. cut its position in CVS Health Corporation (NYSE:CVS – Free Report) by 9.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 470,916 shares of the pharmacy operator’s stock after selling 51,127 shares during the quarter. Cibc World Market Inc.’s holdings in CVS Health were worth $40,353,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CVS. Vawter Financial Ltd. acquired a new stake in shares of CVS Health in the third quarter valued at approximately $257,000. Edgestream Partners L.P. acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $4,610,000. Banco Santander S.A. increased its holdings in shares of CVS Health by 156.1% during the 3rd quarter. Banco Santander S.A. now owns 8,036 shares of the pharmacy operator’s stock worth $689,000 after acquiring an additional 4,898 shares during the last quarter. Western Wealth Management LLC increased its holdings in shares of CVS Health by 10.8% during the 3rd quarter. Western Wealth Management LLC now owns 3,889 shares of the pharmacy operator’s stock worth $333,000 after acquiring an additional 380 shares during the last quarter. Finally, Intech Investment Management LLC raised its stake in CVS Health by 184.1% in the 3rd quarter. Intech Investment Management LLC now owns 151,876 shares of the pharmacy operator’s stock valued at $13,014,000 after acquiring an additional 98,422 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 5.2%

CVS opened at $81.33 on Thursday. The stock has a fifty day moving average of $89.00 and a 200-day moving average of $89.25. The company has a market capitalization of $104.05 billion, a P/E ratio of 9.47, a P/E/G ratio of 0.75 and a beta of 0.58. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85.

CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same period in the prior year, the company posted $1.60 earnings per share. CVS Health’s revenue was up 5.4% compared to the same quarter last year. On average, equities analysts expect that CVS Health Corporation will post 8.26 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s payout ratio is currently 30.97%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CVS. BMO Capital Markets set a $112.00 price target on CVS Health in a report on Wednesday, September 9th. Wells Fargo & Company decreased their price objective on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday, November 12th. Wall Street Zen lowered shares of CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Leerink Partners cut their target price on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a research note on Thursday, November 5th. Finally, Barclays cut their target price on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research note on Thursday, November 5th. Twenty-three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $107.33.

View Our Latest Research Report on CVS

Latest CVS Health News

These are some of the CVS news items that stood out recently:

Insider Activity

In other CVS Health news, EVP Prem Shah bought 23,855 shares of the firm’s stock in a transaction on Friday, November 6th. The shares were purchased at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the transaction, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.85% of the stock is currently owned by insiders.

CVS Health Company Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

See Also

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.